Future Health Pharma GmbH
Future Health Pharma GmbH is a OTC and phyto company based in Wetzikon (Zurich) recorded by Swissmedic as the authorisation holder for 24 human medicines. That places it 79 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | OTC and phyto |
|---|---|
| City | Wetzikon |
| Canton | Zurich |
| Authorisation holder | Yes |
| Medicines | 24 |
| Founded | Not available |
| Employees | 1-10 |
| Parent group | Not available |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Future Health Pharma GmbH is recorded by Swissmedic as the authorisation holder for 24 human medicines. The table shows 24 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
24 of 24 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| abnobaVISCUM Fraxini 20 mg | 68315 | A | L01CX | 2022-10-28 |
| Aldomet 250 | 28080 | B | C02AB01 | 1962-08-17 |
| Baldriparan | 28270 | D | - | 1962-06-06 |
| Baldriparan für die Nacht | 55786 | D | N05CM09 | 2001-06-15 |
| Baqsimi | 67465 | B | H04AA01 | 2020-06-11 |
| Buvidal 8 mg | 67941 | A+ | N07BC01 | 2020-12-17 |
| Dukoral | 704 | B | J07AE01 | 2006-03-29 |
| Helux | 67732 | D | S01GX06 | 2020-02-10 |
| Hexvix | 58015 | B | V04CX06 | 2007-11-06 |
| Indocid-Retard | 40454 | B | M01AB01 | 1977-06-27 |
| Insadol | 68497 | D | A01A | 2024-01-18 |
| IXIARO | 59147 | B | J07BA02 | 2010-05-06 |
| Matrifen 25 ug/h | 57460 | A+ | N02AB03 | 2007-11-22 |
| Miacalcic 100 | 38605 | B | H05BA01 | 1976-05-17 |
| Miacalcic mite 100 | 47473 | B | H05BA01 | 1986-03-18 |
| Nimotop 10 mg/50 ml | 48153 | B | C08CA06 | 1987-05-06 |
| Nimotop 30 mg | 45839 | B | C08CA06 | 1987-05-06 |
| Ozalin 2 mg/ml | 67570 | A | - | 2020-10-08 |
| Pentacarinat | 50635 | A | P01CX | 1990-03-19 |
| Rasilez 150 mg | 58050 | B | C09XA02 | 2007-06-29 |
| Vaxelis 0.5 ml | 66940 | B | J07CA09 | 2019-08-28 |
| Wakix 4.5 mg | 67007 | B | N07XX11 | 2018-12-20 |
| Wilentin 250 mg | 67900 | B | A16AX12 | 2021-12-08 |
| Xermelo 250 mg | 66374 | B | A16AX15 | 2018-03-28 |
Frequently asked questions
How many medicines does Future Health Pharma GmbH have authorised in Switzerland?
Future Health Pharma GmbH is recorded by Swissmedic as the authorisation holder for 24 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Future Health Pharma GmbH based?
The Swiss location recorded for Future Health Pharma GmbH is Wetzikon, Zurich.
Is Future Health Pharma GmbH a Swissmedic authorisation holder?
Yes. Future Health Pharma GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.